Cargando...

Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Avogadri-Connors, Francesca, Cutler, Richard E., Lalani, Alshad S., Dent, Paul
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6707946/
https://ncbi.nlm.nih.gov/pubmed/31489122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27162
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!